基线眼压对LiGHT试验初始治疗反应的影响:选择性激光小梁成形术与药物治疗的比较
该研究为LiGHT试验的事后分析,纳入662例患者共1146眼(SLT组559眼,药物组587眼),比较选择性激光小梁成形术(SLT)与前列腺素类似物(PGA)滴眼液在不同基线眼压下的降眼压反应。结果显示两组在基线及治疗8周时平均眼压无显著差异,基线眼压越高降眼压幅度越大;SLT在较高基线眼压时降眼压更多,PGA在较低基线眼压时降眼压百分比更优。
要点
- 两组在基线及治疗8周时平均眼压无显著差异。
- 基线眼压越高,SLT与PGA的降眼压幅度均越大。
- 基线眼压>22.5 mmHg时SLT达到≥20%降眼压的概率更高(P=0.01)。
核心结论
- 在未治疗眼中,较高基线眼压时SLT比PGA滴眼液更常达到≥20%的降眼压。
- 较低基线眼压时PGA滴眼液的降眼压百分比在统计学上大于SLT,但绝对降幅无此差异,其临床意义不确定。
研究设计与样本
- 激光治疗青光眼与高眼压症试验(LiGHT)的事后分析,纳入662例患者共1146眼,SLT组559眼、药物组587眼。
- 比较SLT或PGA滴眼液治疗后8周的眼压降幅,采用线性混合效应模型检验绝对与百分比降幅差异,采用逻辑混合效应模型估计达到≥20%降眼压的概率差异。
主要发现
- 两组在基线及治疗开始后8周的平均眼压无显著差异。
- 两种治疗均在基线眼压较高时降眼压更多,在基线眼压较低时降眼压更少。
- 基线眼压较高时SLT倾向于比PGA滴眼液降眼压更多;基线眼压≤17 mmHg时PGA滴眼液的百分比降幅与SLT的差异显著。
- 基线眼压与达到≥20%降眼压概率的关系在两种治疗间存在显著差异(P=0.01),基线眼压>22.5 mmHg时SLT比PGA更成功。
关键数值与推荐
- 基线眼压≤17 mmHg时,PGA滴眼液相比SLT的百分比眼压降幅差异显著。
- 基线眼压>22.5 mmHg时,SLT达到≥20%降眼压的概率高于PGA滴眼液(P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The Laser in Glaucoma and Ocular Hypertension Trial demonstrated the efficacy and safety of selective laser trabeculoplasty (SLT) compared with topical hypotensive medication as first-line therapy for ocular hypertension and open-angle glaucoma. This substudy explored the impact of pretreatment (baseline) intraocular pressure (IOP) on treatment response. DESIGN: Post hoc analysis of randomized control trial data. PARTICIPANTS: A total of 1146 eyes from 662 patients were included in this analysis: 559 eyes in the SLT group and 587 in the medication group. METHODS: Intraocular pressure reduction at 8 weeks after treatment with either SLT or prostaglandin analog (PGA) eye drops was assessed at different levels of baseline IOP, and the groups were compared. Differences in absolute and percentage IOP lowering between SLT and PGA groups were tested with a linear mixed-effects model. Differences in the probability of achieving ≥ 20% IOP lowering between SLT and PGA groups, at different levels of baseline IOP, were estimated using a logistic mixed-effects model. MAIN OUTCOME MEASURE: Intraocular pressure-lowering response to SLT versus PGA eye drops. RESULTS: Mean IOP was not significantly different between the groups at baseline or 8 weeks after treatment initiation. Both treatments showed greater IOP lowering at higher baseline IOP and less IOP lowering at lower baseline IOP. Selective laser trabeculoplasty tended to achieve more IOP lowering than PGA drops at higher baseline IOP. Prostaglandin analog drops performed better at lower baseline IOP, and the difference compared with SLT, in terms of percentage IOP reduction, was significant at baseline IOP of ≤ 17 mmHg. A significant difference was found in the relationship between baseline IOP and probability of ≥ 20% IOP lowering between the two treatments (P = 0.01), with SLT being more successful than PGA at baseline IOP of more than 22.5 mmHg. CONCLUSIONS: We confirm previous reports of greater IOP lowering with higher baseline IOP for both SLT and PGA drops. In treatment-naïve eyes, at higher baseline IOP, SLT was more successful at achieving ≥ 20% IOP lowering than PGA drops. At lower baseline IOP, a statistically greater percentage, but not absolute, IOP lowering was seen with PGA drops compared with SLT, although the clinical significance of this is uncertain. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
引用
- Fahy ET, Montesano G, Garg A, et al. The Impact of Baseline Intraocular Pressure on Initial Treatment Response in the LiGHT Trial: Selective Laser Trabeculoplasty versus Medication. Ophthalmology. 2024. PMID: 38964719. doi:10.1016/j.ophtha.2024.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。